Prognosis and treatment of non-metastatic primary and secondary breast angiosarcoma: a comparative study
Open Access
- 27 April 2017
- journal article
- research article
- Published by Springer Science and Business Media LLC in BMC Cancer
- Vol. 17 (1), 295
- https://doi.org/10.1186/s12885-017-3292-7
Abstract
Breast angiosarcoma is a rare malignancy with limited publications confined to small retrospective case reviews and case reports. Knowledge of this disease is limited because information from previous studies is insufficient and inconsistent. We obtained data from the Surveillance, Epidemiology, and End Results Program for non-metastatic primary and secondary breast angiosarcoma, and performed analysis to determine clinicopathological characteristics and estimate their associations with overall survival (OS). Median age was 50–54 years in primary breast angiosarcoma and 70–74 years in secondary breast angiosarcoma, while median OS was 93 and 32 months, respectively. Age, tumor grade and tumor spread were associated with poor survival outcomes. Compared with primary breast angiosarcoma, patients with secondary breast angiosarcoma had a “nominal” increased death risk (HR = 1.89, 95% CI, 1.43–2.50, p < 0.001), which was driven by older age and more aggressive tumor phenotype at presentation. Mastectomy was associated with worse OS compared with breast conservative surgery (BCS) (adjHR = 2.47, 95% CI, 1.29–4.74) in primary angiosarcoma patients. Adjuvant radiation was associated with worse OS in secondary angiosarcoma patients (adjHR =1.77, 95% CI, 1.01–3.12). There is a “nominal” increased death risk in secondary breast angiosarcoma due to advanced clinicopathological features. Both BCS and mastectomy are feasible in primary and secondary angiosarcoma if R0 can be achieved. Routine radiation in unselected breast angiosarcoma should be cautious because there is no survival benefit in primary AS and appeared to be associated with a worse OS in secondary AS.Keywords
This publication has 13 references indexed in Scilit:
- Soft tissue and visceral sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upAnnals of Oncology, 2014
- Treatment and prognostic factors of radiation-associated angiosarcoma (RAAS) after primary breast cancer: A systematic reviewEuropean Journal of Cancer, 2014
- Cutaneous Radiation-Associated Angiosarcoma of the Breast: Poor Prognosis in a Rare Secondary MalignancyAnnals of Surgical Oncology, 2012
- Radiation-Associated Angiosarcoma After Breast Cancer: High Recurrence Rate and Poor Survival Despite Surgical Treatment with R0 ResectionAnnals of Surgical Oncology, 2012
- Radiation-Induced Sarcoma of the Breast: A Systematic ReviewThe Oncologist, 2012
- Surgical management of radiation-induced angiosarcoma after breast conservation therapyThe American Journal of Surgery, 2011
- Outcome and prognostic factors in breast sarcoma: A multicenter study from the rare cancer networkRadiotherapy and Oncology, 2007
- Angiosarcomas, a heterogeneous group of sarcomas with specific behavior depending on primary site: a retrospective study of 161 casesAnnals of Oncology, 2007
- Prognostic Factors in Primary Breast Sarcomas: A Series of Patients With Long-Term Follow-UpJournal of Clinical Oncology, 2003
- Angiosarcoma after breast‐conserving therapyCancer, 2003